| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/05/2003 | US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 08/05/2003 | US6602875 Sorbitol dehydrogenase inhibitors |
| 08/05/2003 | US6602863 Irreversible inhibitors of tyrosine kinases |
| 08/05/2003 | US6602826 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 08/05/2003 | CA2089148C Oxidized complex comprising water-soluble carboxypolysaccaride and magnetic iron oxide |
| 07/31/2003 | WO2003063555A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/31/2003 | WO2003062227A1 Rho-kinase inhibitors |
| 07/31/2003 | WO2003062226A1 Quinazoline(di) ones for invertebrate pest control |
| 07/31/2003 | WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | WO2003062211A1 Pyrimidinone viral polymerase inhibitors |
| 07/31/2003 | WO2003062210A1 Process for preparation of pyrimidinyl alcohol derivatives and intermediates for the synthesis thereof |
| 07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 07/31/2003 | WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 07/31/2003 | WO2003047516A3 Pyrimidine compounds |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003039460A3 Mitotic kinesin inhibitors |
| 07/31/2003 | WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 07/31/2003 | WO2002094767A3 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144509 Prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. |
| 07/31/2003 | US20030144342 alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics |
| 07/31/2003 | US20030144311 Propanoic acid derivatives as intergrin receptor antagonists |
| 07/31/2003 | US20030144307 2,6-Disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease |
| 07/31/2003 | US20030144305 Novel compounds |
| 07/31/2003 | US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 07/31/2003 | US20030144178 Administering 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline or 4-(3'-bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline |
| 07/31/2003 | US20030143430 Durability; decreased driving voltage |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | CA2473508A1 Pyrimidinone viral polymerase inhibitors |
| 07/31/2003 | CA2455844A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 07/30/2003 | EP1330444A2 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 07/30/2003 | EP1330443A1 Substituted phenyluracils |
| 07/30/2003 | EP1330292A2 Radioactive member for use in brachytherapy and method of making |
| 07/30/2003 | EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/30/2003 | EP1137622B1 Method of preparing salts of dinitromethane |
| 07/30/2003 | EP1012146B1 Hiv nuclear localization inhibitors |
| 07/30/2003 | EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 07/30/2003 | CN1433417A Pyridopyrimidinone derivatives for treatment of neurodegenerative disease |
| 07/30/2003 | CN1433405A Quinazoline compounds |
| 07/30/2003 | CN1433312A Barbituric acid analogs as therapeutic agents |
| 07/30/2003 | CN1433297A Topical compositions comprising protected functional thiols |
| 07/30/2003 | CN1116286C 4-anilinoquinazoline derivatives |
| 07/30/2003 | CN1115959C Method for raising whole someness of preventing and control of mite |
| 07/29/2003 | US6600043 Carboxylic acid derivatives, their preparation and use |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6599908 Fused polycyclic 2-aminopyrimidine derivatives |
| 07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/29/2003 | US6599590 Unsaturated fluorine compound |
| 07/24/2003 | WO2003059892A1 Substituted alkyl uracils and the use thereof |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139431 Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139403 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139397 Pesticides |
| 07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | CA2473362A1 Substituted alkyl uracils and the use thereof |
| 07/23/2003 | EP1056742B1 Anti-viral pyrimidine derivatives |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |
| 07/23/2003 | EP0763529B1 Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
| 07/23/2003 | CN1432017A Triazolo pyrimidine compounds |
| 07/23/2003 | CN1432003A Process to prepare sulfonamides |
| 07/23/2003 | CN1431195A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate and its prepn. process |
| 07/23/2003 | CN1431194A Synthesis of 5-(3-[exo-dicyclo [2,2,1] heptyl-2-ylidene oxy]-4-methoxy phenyl)-3,4,5,6-tetrahydropyrimidine-2 (1H) ketonic intermediate, and its prepn. process |
| 07/23/2003 | CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol |
| 07/23/2003 | CN1115339C Novel sulfonylaminopyrimidines |
| 07/23/2003 | CN1115338C Method for producing 4ÒÇö(2',5'-diamino-6'-halopyrimidine-4'-yl) aminoÒÇò-cyclopent-2-enylmethanols |
| 07/23/2003 | CN1115337C Pyrimidinone derivatives |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596727 Substituted pyrimidines, processes for their preparation, and their use as pesticides and fungicides |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/22/2003 | US6596723 Fungal efflux pump inhibitors |
| 07/22/2003 | US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 07/22/2003 | US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells |
| 07/22/2003 | US6596193 Reactive liquid crystal compounds; improves switching times especially at low temperatures |
| 07/17/2003 | WO2003057677A1 Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2003043979A3 Pharmaceutically active compounds and methods of use thereof |
| 07/17/2003 | WO2002099124A3 Characterising polypeptides |
| 07/17/2003 | US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/17/2003 | US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate |
| 07/17/2003 | US20030135047 By reacting 4,6-dichloro-2-(methylthio)pyrimidine in an inert organic solvent with an alkali metal methoxide, transferring to an aqueous acid medium and oxidation; using the product to prepare 7-((4,6- |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134838 Treatment of illnesses in which beta -amyloid modulators have a therapeutic benefit, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof. |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |